Business & Regulation

It’s relatively simple: Follow cGMP, keep your facilities clean, keep vermin out, and don’t sell unapproved products…

An inside view of the pharmaceutical industry in China. Where has it been, where does it stand, and where is it going?

It’s been a busy time for infectious disease vaccine news in Europe.

Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences.

What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic?

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

How we can begin overcoming patients’ fears and misconceptions of cell and gene therapy

Can AI help us better understand and define chronic pain?

How AI can be leveraged to improve patient acquisition.